An aerosol formulation of R-salbutamol sulfate for pulmonary inhalation

Akinbami LJ, Moorman JE, Bailey C, Zahran HS, King M, Johnson CA., et al. Trends in asthma prevalence, health care use, and mortality in the United States, 2001–2010. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics. 2012. Available from: 〈http:/www.cdc.gov/nchs/data/databriefs/db94.htm〉. Lin JT, Su N, Liu GL, Yin KS, Zhou X, Shen HH, etal. The impact of concomitant allergic rhinitis on asthma control: a cross-sectional nation wide survey in China. J Asthma 2013 October 4. Available from: 10.3109/02770903.2013.840789 Chen, 2013, Asthma research in China: a five-year review, Respirology, 18 Suppl 3, S10, 10.1111/resp.12196 Chen, 2005, Prevention and treatment of childhood asthma in China, World J Pediatr, 1, 85 Hong, 2007, Global initiative for asthma 2006, J Appl Clin Pediatr, 22, 1278 Jones, 2013, Management of acute asthma in the pediatric patient: an evidence-based review, Pediatr Emerg Med Pract, 10, 1 Wang, 2011, Management of severe asthma exacerbation in children, World J Pediatr, 7, 293, 10.1007/s12519-011-0325-1 Mazzoni, 1994, Hyperresponsiveness of the airways following exposure of guinea-pigs to racemic mixtures and distomers of β2-selective sympathomimetics, Pulm Pharmacol, 7, 367, 10.1006/pulp.1994.1043 Templeton, 1998, Effects of S-salbutamol on human isolated bronchus, Pulm Pharmacol Ther, 11, 1, 10.1006/pupt.1998.0110 Agrawal, 2004, (S)-Albuterol activates pro-constrictory and pro-inflammatory pathways in human bronchial smooth muscle cells, J Allergy Clin Immunol, 113, 503, 10.1016/j.jaci.2003.12.039 Ameredes, 2005, Modulation of GM-CSF release by enantiomers of β-agonists in human airway smooth muscle, J Allergy Clin Immunol, 116, 65, 10.1016/j.jaci.2005.03.007 Chorley, 2006, (R)-albuterol elicits antiinflammatory effects in human airway epithelial cells via iNOS, Am J Respir Cell Mol Biol, 34, 119, 10.1165/rcmb.2005-0338OC Cho, 2001, (S)-Albuterol increases the production of histamine and IL-4 in mast cells, Int Arch Allergy Immunol, 124, 478, 10.1159/000053783 Nigo, 2006, Regulation of allergic airway inflammation through Toll-like receptor 4-mediated modification of mast cell function, Proc Natl Acad Sci U S A, 103, 2286, 10.1073/pnas.0510685103 Walle, 1993, Stereoselective sulphate conjugation of salbutamol in humans: comparison of hepatic, intestinal and platelet activity, Br J Clin Pharmacol, 35, 413, 10.1111/j.1365-2125.1993.tb04159.x Schmekel, 1999, Stereoselective pharmacokinetics of S-salbutamol after administration of the racemate in healthy volunteers, Eur Respir J, 13, 1230, 10.1034/j.1399-3003.1999.13f04.x Goldstein, 1987, Pharmacokinetics and absolute bioavailability of salbutamol in healthy adult volunteers, Eur J Clin Pharmacol, 32, 631, 10.1007/BF02456001 DeNicola, 2001, Drug therapy approaches in the treatment of acute severe asthma in hospitalised children, Paediatr Drugs, 3, 509, 10.2165/00128072-200103070-00003 Tomaszewski, 1994, Stereoisomeric drugs: FDA's policy statement and the impact on drug development, Drug Dev Ind Pharm, 20, 119, 10.3109/03639049409039080 Tucker, 2000, Chiral switches, The Lancet, 355, 1085, 10.1016/S0140-6736(00)02047-X Gradon, 2013, Formation of particles for dry powder inhalers, Adv Powder Technol, 3, 509 Krebs, 2013, Evaluation of a high-dose continuous albuterol protocol for treatment of pediatric asthma in the emergency department, Pediatr Emerg Care, 29, 191, 10.1097/PEC.0b013e3182809b48 Dennis, 2007, European Pharmaceutical Aerosol Group (EPAG) nebulizer sub-team: assessment of proposed European Pharmacopoeial (Ph. Eur.) monograph Preparations for Nebulization, J Aerosol Med, 20, 40 Yan, 2011, Critical evaluation of determination methods of the particle size dry powder inhaler: a comparison of three impactors, Chin J Pharm Anal, 31, 1296 Asmus, 2000, Levalbuterol nebulizer solution: is it worth five times the cost of albuterol?, Pharmacotherapy, 20, 123, 10.1592/phco.20.3.123.34776 Vargas, 2010, Airway responsiveness measured by barometric plethysmography in guinea pigs, Vet Res Commun, 34, 589, 10.1007/s11259-010-9430-1 Begin, 1975, Flow and age dependence of airway closure and dynamic compliance, J Appl Physiol, 38, 199, 10.1152/jappl.1975.38.2.199 Tzou, 1997, Drug form selection in albuterol-containing metered-dose inhaler formulations and its impact on chemical and physical stability, J Pharm Sci, 86, 1352, 10.1021/js970225g Mälkki, 1990, Decomposition of salbutamol in aqueous solutions. I. The effect of pH, temperature and drug concentration, Int J Pharm, 63, 17, 10.1016/0378-5173(90)90095-L Mälkki-Laine, 1995, Decomposition of salbutamol in aqueous solutions. II. The effect of buffer species, pH, buffer concentration and antioxidants, Int J Pharm, 117, 189, 10.1016/0378-5173(94)00329-4 Świercz, 2008, Pulmonary irritation after inhalation exposure to benzalkonium chloride in rats, Int J Occup Med Environ Health, 21, 157, 10.2478/v10001-008-0020-1 Mitchell, 2004, Particle size analysis of aerosols from medicinal inhalers, KONA, 22, 32, 10.14356/kona.2004010 Shekunov, 2007, Particle size analysis in pharmaceutics: principles, methods and applications, Pharm Res, 24, 203, 10.1007/s11095-006-9146-7 Loffert, 1994, A comparison of commercial jet nebulizers, Chest, 6, 788 Hess, 1996, Medication nebulizer performance effects of diluent volume, nebulizer flow, and nebulizer brand, Chest, 110, 98, 10.1378/chest.110.2.498 Zhou, 2005, Medical nebulizer performance: effects of cascade impactor temperature, Respir care, 50, 1077 Dennis, 2008, Cooling the NGI-an approach to size a nebulised aerosol more accurately, Pharmeur Sci Notes, 1, 27 Nelson, 1998, Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthma, J Allergy Clin Immunol, 102, 943, 10.1016/S0091-6749(98)70332-X Auclair, 2000, A population analysis of nebulized (R)-albuterol in dogs using a novel mixed gut-lung absorption PK-PD model, Pharm Res, 17, 1228, 10.1023/A:1026466730347 Ward, 2000, Enantiomeric disposition of inhaled, intravenous and oral racemic-salbutamol in man–no evidence of enantioselective lung metabolism, Br J Clin Pharmacol, 49, 15, 10.1046/j.1365-2125.2000.00102.x